Athira Pharma to Present at Stifel 2022 Healthcare Conference
BOTHELL, Wash., Nov. 09, 2022 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that members of Athira’s management team will participate in the Stifel 2022 Healthcare Conference taking place Nov. 15-16, 2022 in New York City. Members of management will participate in a fireside chat on Wednesday, Nov. 16, 2022 at 4:45 p.m. EST.
Related news for (ATHA)
- Don’t Miss Out: MoBot’s Latest Stock Updates 06/03/25 05:00 AM
- Today’s Top Performers: MoBot’s Market Review 06/03/25 04:00 AM
- Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
- Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
- Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates